← All trials
NCT04471519
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Jun 30, 2021
- First posted
- Jul 15, 2020
- Last posted
- Oct 1, 2020
- Enrollment
- 755
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bharat Biotech International LimitedLead sponsor
- Nizam's Institute of Medical Sciences, Hyderabad, IndiaOverall official - principal investigator
- Indian Council of Medical ResearchCollaborator
- All India Institute of Medical SciencesOverall official - principal investigator
- Gillukar Multispeciality Hospital, NagpurOverall official - principal investigator
- IMS & SUM Hospital, OrissaOverall official - principal investigator
- Jeevan Rekha Hospital, BelguamOverall official - principal investigator
- King George Hospital VisakhapatnamOverall official - principal investigator
- Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical SciencesOverall official - principal investigator
- Prakhar Hospital, KanpurOverall official - principal investigator
- Rana Hospital and Trauma Centre, GorakhpurOverall official - principal investigator
- Redkar Hospital and Research Centre GoaOverall official - principal investigator
- SRM Hospital and Research Centre, ChennaiOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.